Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists
Open Access
- 8 April 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2021.00049
Abstract
The recognition of transarterial chemoembolization (TACE) failure/refractoriness among Chinese clinicians remains unclear. Using an online survey conducted by the Chinese College of Interventionalists (CCI), the aim of this study was to explore the recognition of TACE failure/refractoriness and review TACE application for hepatocellular carcinoma (HCC) treatment in clinical practice.Keywords
This publication has 26 references indexed in Scilit:
- Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled StudyRadiology, 2014
- Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma with Portal Vein Invasion: Safety, Efficacy, and Prognostic FactorsJournal of Vascular and Interventional Radiology, 2014
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score AnalysesRadiology, 2013
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnnals of Oncology, 2013
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinomaJournal of Hepatology, 2013
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)Liver International, 2012
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment DecisionsSeminars in Liver Disease, 2012
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus SorafenibRadiology, 2012
- Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall SurvivalRadiology, 2011
- Transarterial Chemoembolization for Hepatocellular Carcinoma: Volumetric and Morphologic CT Criteria for Assessment of Prognosis and Therapeutic Success—Results from a Liver Transplantation CenterRadiology, 2000